You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康芝藥業(300086.SZ):目前公司生產及銷售的產品有抗病毒藥品等等
格隆匯 06-15 08:24

格隆匯6月15日丨有投資者向康芝藥業(300086.SZ)提問,“針對國內北京和廣東兩地發現4例猴痘病例,康芝藥業生產的藥品對其是否可以治療或者輔助治療有幫助。”

康芝藥業回覆稱,目前公司生產及銷售的產品有抗病毒藥品,如抗病毒口服液、利巴韋林顆粒;清熱解毒的藥品,如感冒清熱顆粒、小兒清熱顆粒、柴黃清熱顆粒、複方板藍根顆粒、銀胡感冒散等;止咳化痰藥品,如止咳橘紅顆粒、小兒咽扁顆粒、小兒化痰止咳顆粒、羧甲司坦顆粒、強力枇杷露、杏仁止咳糖漿、麻杏止咳糖漿等;解熱鎮痛藥品,如布洛芬顆粒、尼美舒利顆粒、尼美舒利分散片、尼美舒利緩釋膠囊等。公司的產品信息請詳見公司4月24日披露的2022年年度報吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account